
Attovia Therapeutics
Attovia, a California-based medical firm, develops biotherapeutics for immune diseases and oncology using a novel nanobody platform.
- 44
- Company
- San Carlos, CA, USUnited States
Attovia is focused on creating a pipeline of biotherapeutics in immune-mediated disease and oncology. The company leverages AttobodyTM, Alamar Biosciences’ novel biparatopic nanobody platform, to generate small format binders with low picomolar affinity, enhanced specificity, accelerated internalization and fast tissue penetration.
Attovia’s lead program is an Attobody to treat immune disease. The company is currently progressing multiple programs and plans to initiate additional discovery projects.
Similar Companies

Celestica

ResMed

Biogen

Revolution Medicines

Otsuka Holdings

BeOne Medicines

Illumina

Sandoz

Idexx
Haleon

Iqvia

Waters

Samsung Biologics

Bayer

Galderma

Lonza

argenx
UCB

Natera

Wuxi Apptec
CSL

Moderna

Sanofi

GSK

Bristol Myers Squibb

Vertex Pharmaceuticals

Danaher

Pfizer

Novo Nordisk

Gilead Sciences

Amgen

Thermo Fisher Scientific

AstraZeneca

Novartis

Merck

Roche Holding

AbbVie

Johnson & Johnson

Eli Lilly and Company

Design Therapeutics
Quick Facts
Who are Attovia Therapeutics' competitors?
Companies similar to Attovia Therapeutics include Celestica, ResMed, Biogen and Revolution Medicines.
When was Attovia Therapeutics founded?
Attovia Therapeutics was founded in 2023.
Where is Attovia Therapeutics' headquarters located?
Attovia Therapeutics' headquarters is located in San Carlos, CA, US.
When was Attovia Therapeutics' last funding round?
Attovia Therapeutics' most recent funding round was for $289M (USD) in August 2026.
How much disclosed funding has Attovia Therapeutics raised?
As of Aug 4, 2026, Attovia Therapeutics has disclosed funding of $544M (USD). Undisclosed round amounts are excluded.
How many employees does Attovia Therapeutics have?
Attovia Therapeutics has 44 employees as of Oct 28, 2026.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Revenue
- Main Product
- Tags
- Headquarters
- 1091 Industrial Rd
- Ste 310
- San Carlos, CA, 94070
- US
- Ticker
- ATTO
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Medical Organizations
Show 4 more industry codes
- NAICS
- 620000Health Care and Social Assistance
- SIC
- 8000Health Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified